NCT06338215 Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality
| NCT ID | NCT06338215 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Clinica Universidad de Navarra, Universidad de Navarra |
| Condition | All Cause Mortality |
| Study Type | INTERVENTIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2024-05-15 |
| Primary Completion | 2028-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10,000 participants in total. It began in 2024-05-15 with a primary completion date of 2028-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to test two advices on alcohol drinking in more than 10.000 Spanish adult drinkers (men of 50 or more years and women of 55 or more years). The main question it aims to answer is to test the non-inferiority advice of a moderate alcohol drinking pattern on all-cause mortality and other chronic disease like cardiovascular disease, cancer or type 2 diabetes. Participants will receive during 4 years an advice to drink alcohol following a Mediterranean Alcohol Drinking Pattern (MADP): consuming alcohol in moderation, avoidance of binge drinking and preference for red wine. Researchers will compare those who will receive a MADP advice with those who will receive an advice on abstention to see if the advice on MADP is not inferior than the abstention advice to prevent all-cause mortality and other chronic diseases.
Eligibility Criteria
Inclusion Criteria: * Males aged 50-70 years, Women aged 55-75 years * Drinkers of any alcoholic beverage initially consuming 3 or more but 40 or less drinks/wk * Projected life expectancy more than 5 years (according to the judgment of their attending physician) * Willing to receive advice during up to 4 years on how to improve their alcohol intake making it healthier Exclusion Criteria: 1. Participants without smartphone or a computer (or tablet) with Internet connection. 2. Drinkers of less than 30 g of pure alcohol/wk or more than 400 g of pure alcohol/wk 3. Illiteracy, inability/unwillingness to give written consent or communicate with study staff, or inadequate abilities for the use of on-line technologies 4. Participants with any sever psychiatric condition or with a diagnosis of cognitive impairment or dementia. 5. Participants with liver cirrhosis or prior liver cancer. 6. Patients with a recent diagnosis of breast cancer (diagnosed in the last 10 years). 7. Patients under habitual use of high-dose medications that completely preclude any use of alcohol. Most of these patients will be already excluded by the second or fourth exclusion criteria.
Contact & Investigator
Miguel A Martinez-Gonzalez, MD, MPH, PhD
PRINCIPAL INVESTIGATOR
University of Navarra
Frequently Asked Questions
Who can join the NCT06338215 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 75 Years, studying All Cause Mortality. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06338215 currently recruiting?
Yes, NCT06338215 is actively recruiting participants. Contact the research team at mamartinez@unav.es for enrollment information.
Where is the NCT06338215 trial being conducted?
This trial is being conducted at Pamplona, Spain.
Who is sponsoring the NCT06338215 clinical trial?
NCT06338215 is sponsored by Clinica Universidad de Navarra, Universidad de Navarra. The principal investigator is Miguel A Martinez-Gonzalez, MD, MPH, PhD at University of Navarra. The trial plans to enroll 10,000 participants.